Abstract
Kidney involvement in ANCA-associated vasculitis is common (64%–85%) and associated with high morbidity and mortality. Despite recent advances in therapy, a significant number of patients still progress to kidney failure or death. As such, therapies that improve kidney outcomes have been pursued
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for freeCite
CITATION STYLE
APA
De Vriese, A. S., & Fervenza, F. C. (2021). PEXIVAS. Clinical Journal of the American Society of Nephrology, 16(2), 307–309. https://doi.org/10.2215/cjn.10550620
Readers' Seniority
Readers' Discipline
